TDOC

$5.61

Post-MarketAs of Mar 17, 8:00 PM UTC

Teladoc Health, Inc.

Historical Price

Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$5.61
Potential Upside
5%
Whystock Fair Value$5.89
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryHealth Information Services

Teladoc Health, Inc. provides virtual healthcare services worldwide. It operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical se...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.00B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
2.19
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-13.93%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
2.43

Recent News

StockStory
Mar 16, 2026

Online Marketplace Stocks Q4 In Review: Teladoc (NYSE:TDOC) Vs Peers

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Teladoc (NYSE:TDOC) and the rest of the online marketplace stocks fared in Q4.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Motley Fool
Mar 12, 2026

Stock Market Today, March 12: Hims and Hers Health Drops After Rally Sparks Profit Taking

On March 12, 2026, investors weighed profit-taking against a high-stakes pivot toward branded obesity drugs and telehealth growth.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Mar 12, 2026

Hims & Hers Plunges 29.4% in Three Months: How to Play the Stock?

HIMS is navigating margin and regulatory pressure, but new benefits, a Novo Nordisk tie-up and platform growth could drive its next move.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Mar 12, 2026

A Look At Teladoc Health’s (TDOC) Valuation After Analyst Upgrades And Earnings Surprise

Why Teladoc Health is back on investors’ radar Teladoc Health (TDOC) is attracting fresh attention after a run of analyst upgrades tied to its BetterHelp mental health segment, stronger than expected quarterly results, and new plans around artificial intelligence and international expansion. See our latest analysis for Teladoc Health. Despite the recent enthusiasm around upgrades and earnings, Teladoc Health’s 7 day share price return of 6.63% and 30 day gain of 9.84% sit against a much...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Mar 11, 2026

Teladoc (TDOC) Falls More Steeply Than Broader Market: What Investors Need to Know

In the latest trading session, Teladoc (TDOC) closed at $5.47, marking a -1.8% move from the previous day.

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.